Reinventing phage therapy: are the parts greater than the sum?
Although whole phage continue to generate interest as an alternative to antibiotics, focus is shifting to the use of purified phage components as antibacterial agents.
Fischetti
Vincent A
VA
Laboratory of Bacterial Pathogenesis and Immunology, Rockefeller University, New York, New York 10021, USA. vaf@rockefeller.edu
Nelson
Daniel
D
Schuch
Raymond
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000628:therapy*; D001435:Bacteriophages / Q000378:metabolism*; D006801:Humans; D014764:Viral Proteins / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014764:Viral Proteins